Syndax Pharmaceuticals, Inc. (SNDX) vs Tyra Biosciences, Inc. (TYRA)
Syndax Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Syndax Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are of similar size ($1.6B and $1.5B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 14 metrics below, Tyra Biosciences, Inc. leads on 10 and Syndax Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | SNDX | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.78% | 0.00% | 65.16% |
| Operating margin | (77.05%) | 0.00% | 0.00% |
| Net margin | (87.60%) | 0.00% | 0.00% |
| Free cash flow margin | (87.64%) | 0.00% | 0.00% |
| Return on equity | (255.93%) | (45.31%) | (57.72%) |
| Return on assets | (33.97%) | (42.15%) | (49.22%) |
| Return on invested capital | (247.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack